Antiviral Chemotherapy 1 - NRTI + NNRTI Flashcards

(24 cards)

1
Q

What are the 3 main enzymes in HIV?

A

Integrase
Reverse transcriptase
Protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe reverse transcriptase

A

First uses RNA then DNA as a template
Endonuclease activity = degradation of the RNA strand of the RNA/DNA hybrid
Needed for transcription of viral genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe process of reverse transcriptase

A

Reverse transcriptase = reading RNA + making complementary strand
RNase H/Reverse transcriptase = chop out RNA = 2nd strand of DNA = double strand
Integrase = insert into host cell genome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the structure of reverse transcriptase?

A

Heterodimeric enzyme
2 polypeptides
p51 unit lacks the RNase functional region
Described as a right hand with palm, fingers + thumb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the chemistry of reverse transcriptase

A

3’-OH (strong Lewis base) of primer terminus lies in proximity to a triad of aspartic residues in active site
2Mg2+ (strong Lewis acid - in active site) = interact with triphosphate + 3’ terminus of primer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the right hand structure model

A

Fingers = provide a channel = can move
Thumb = involves translocation = hold on genetic material + moving
Catalytic aspartates = hold 2 metal ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the 2 classes of reverse transcriptase inhibitors?

A

Nucleoside inhibitors (NRTIs)
Non nucleoside inhibitors (NNRTIs) = these bind at hydrophobic pockets adjacent to active site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does NRTIs work?

A

Analogues of endogenous 2’-deoxy-nucleosides/tides
Must be phosphorylated = active = anti-viral effect
Cell full of kinase - phosphorylate
Hydrophilic = limited membrane permeability = transported into cell via solute carrier transporters
Lack 3’-hydroxyl group - prevent chain elongation = chain-terminators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is a problem with NRTIs being phosphorylated?

A

Significant SEs = potential toxicity with mitochondrial polymerase enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What was the first NRTI?

A

AZT
= acts via triphosphate metabolite to inhibit RT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is reverse transcriptase downfall?

A

Has no proof reading
= drug attaches
= can’t reverse it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is HARRT?

A

Highly active antiretroviral therapy
= initiated with 2 NRTIs + 1 NNRTI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Who is 2 NRTI + protease inhibitor for?

A

Resistance to 1st line
Women wishing to become pregnant
Psychiatric disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the metabolism + toxicity associated with NRTIs?

A

Majority dose excreted unchanged = highly polar drugs
Toxicities associated with inhibition of mitochondrial polymerase-gamma = increased plasma lactate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the chemistry for Tenofovir?

A

LogP = -4
Orally available at LogP = 0-5
= a pro-drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe Tenofovir Disoproxil Fumarate (pro-drug)

A

Improved cell permeability = orally available
BUT associated with effects on renal function + BMD
Renal accumulation = efficient uptake from plasma = reduced efflux into urine

17
Q

Describe Tenofovir Alafenamide (pro-drug)

A

Higher delivery target cells
Reduced kidney damage
Reduced bone demineralisation

18
Q

Where does NNRTIs bind?

A

Allosteric binding site

19
Q

How does NNRTIs work?

A

Pocket = hydrophobic
Causes conformational change = causes movement of aspartic acid residues in active site
= inhibiting enzyme
Slightly decreases function of RNase

20
Q

Describe the structure of 1st generation of NNRTIs

A

Rigid structures = fixed structure (planar)

21
Q

Describe the structure of 2nd generation of NNRTIs

A

Flexibility = rotation around the bonds
= can still bind with resistant strains

22
Q

What are NNRTIs metabolised by?

23
Q

Describe the pharmacodynamics + physiochemical properties of Rilpivirine

A

pKa = 5.6 (weak base)
Poorly H2O soluble
Lower incidence of CNS effects
NOT recommended for breastfeeding mothers

24
Q

Describe the pharmacodynamics + physiochemical properties of Doravirine

A

pKa = 3.51 (acidic centre)
Quickly absorbed after oral (not impacted by food)
Pharmacokinetics NOT affected by age, gender or ethnicity
NO dose adjustment for patients with hepatic impairment